The effort, known as the Louisiana AI Drug Development Infrastructure for ALS, brings together leading institutions and innovators, including GATC Health, and LA CaTS Center partnering institutions Pennington Biomedical Research Center and Tulane University. The ultimate goal is to identify and prioritize therapeutic targets using AI-driven insights from the Answer ALS’ Neuromine Data Portal, the largest open-access ALS dataset in the world.
See Pennington Biomedical's news release HERE.
Read article by The Advocate HERE.